Postmenopausal Vaginal Atrophy Treatment Market 2022 Driving Factors Forecast Research 2028

The Postmenopausal Vaginal Atrophy Treatment Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2022-2028). Postmenopausal vaginal atrophy (PVA) is a decrease in estrogen production after menopause, also known as vaginal atrophy. When estrogen is low, vaginal tissue becomes thinner, drier, and less elastic. Various other factors that reduce estrogen levels include peri- and post-menopause while breastfeeding, surgical menopause, pelvic radiation therapy, and chemotherapy. Symptoms of vaginal atrophy include redness, burning, itching, dyspareunia, and irritation. Diagnosis of PVA includes a pelvic exam, vaginal smear, vaginal activity tests, blood tests, and urine tests.

The following segmentation are covered in this report:

By Drug Form

• Vaginal Gels
• Creams
• Tablets
• Rings
• Patches

By Therapy Type

• Estrogen-Based Drugs
• Premarin
• Vagifem
• Estrace
• Estring
• Femring
• Non-Estrogen-Based Drugs
• BZA/CE
• Osphena
• Vaginorm

Company Profile

• Actavis plc
• Bionovo, Inc.
• Endoceutics, Inc.
• Novo Nordisk AS
• Pfizer Inc.
• Teva Pharmaceuticals Ltd.
• Therapeutics MD, Inc.
• Shionogi and Company, Limited
• Allergan plc
• Shionogi and Co. Ltd

Scope of the report

The research study analyses the Postmenopausal Vaginal Atrophy Treatment Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North America market size and/or volume
• Latin America market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Postmenopausal Vaginal Atrophy Treatment Market Report

• What was the Postmenopausal Vaginal Atrophy Treatment Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the Postmenopausal Vaginal Atrophy Treatment Market CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Postmenopausal Vaginal Atrophy Treatment Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.